logo
Select company
Select metric
$ 15.38MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
42
Sector
78
Industry
91
History
100
$ 3.16Close
$ 1.37 - $ 4.01 52-Week Range
Ticker Information

Ticker

AKBA

Company Name

AKEBIA THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

AKEBIA THERAPEUTICS INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AKBA - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 23.72M$ -8.34M$ 15.38M
3/31/2025$ 32.73M$ -21.86M$ 10.87M
12/31/2024$ 41.7M$ -51.23M$ -9.52M
9/30/2024$ 46.12M$ -33.27M$ 12.85M
6/30/2024$ 44.83M$ -32.97M$ 11.86M
3/31/2024$ 43.41M$ -36.06M$ 7.34M
12/31/2023$ 41.85M$ -45.89M$ -4.05M
9/30/2023$ 35.82M$ -54.84M$ -19.02M
6/30/2023$ 35.48M$ -89.68M$ -54.19M
3/31/2023$ 35.24M$ -44.17M$ -8.93M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AKEBIA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA stands at $ -352.8M.
  • Over the past 5 years, AKEBIA THERAPEUTICS INC's average EBITDA has been $ -113.99M.
  • The median EBITDA for AKEBIA THERAPEUTICS INC during this period was $ -47.89M
  • AKEBIA THERAPEUTICS INC reached its highest EBITDA over the past 5 years at $ 15.38M.
  • The lowest EBITDA recorded by AKEBIA THERAPEUTICS INC in the same timeframe $ -352.8M

AKEBIA THERAPEUTICS INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
STOK : STOKE THERAPEUTICS INC $ 44.92MDNA : GINKGO BIOWORKS HOLDINGS INC $ -222.12MDAWN : DAY ONE BIOPHARMACEUTICALS INC $ -86.04MGERN : GERON CORP $ -58.41MIOVA : IOVANCE BIOTHERAPEUTICS INC $ -343.89MMRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ -101.19MKROS : KEROS THERAPEUTICS INC $ 30.57MCRMD : CORMEDIX INC $ 52.25MNAGE : NIAGEN BIOSCIENCE INC $ 19.78MZYME : ZYMEWORKS INC $ -54.55M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for AKEBIA THERAPEUTICS INC is calculated as follows: EBIT [ $ -386.14M ] + DepAmor [ $ 33.34M ]
(=) EBITDA [ $ -352.8M ]

AKBA - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -352.8M

Minimum

Sep 30, 2020

$ 15.38M

Maximum

Jun 30, 2025

$ -113.99M

Average

$ -47.89M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.76M with a standard deviation of $ 166.93M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.76M
median$ 8.83M
std$ 166.93M